Live News Categoriesmarket

NBIX.US.EQUI (NBIX.US.EQUI) News

Follow NBIX.US.EQUI (NBIX.US.EQUI) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol NBIX.US.EQUI Asset market Sector Markets 90 days 1 Updated Jul 07, 2026, 11:21 AM UTC Open live news feed

H Neurocrine price target raised to $195 from $183 at RBC Capital RBC Capital analyst Brian Abrahams raised the firm's price target on Neurocrine to $195 from $183 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The bio EQUITY | Jul 07, 2026, 11:21 AM UTC